from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0374c/-

LFCtreatmentdescriptionclass of inhibitor

-1.110

Amikacinug/mL Amikacintranslation

-0.155

Cap5-10ug/mL Capreomycintranslation

0.484

Rox10-50 ug/mL Roxithromycintranslation

-0.185

SM2-5 ug/mL Streptomycintranslation

-0.668

Tet5-10 ug/mL Tetracyclinetranslation

-1.843

Rif0.2-5ug/mL Rifampicintranscription

-0.604

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.504

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.110

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.378

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.486

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.557

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.725

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.950

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.849

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.086

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.240

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.096

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.434

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.200

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.516

KCN5-20 ug/mL Potassium cyaniderespiration

-0.337

NaN30.2-2 mM Sodium aziderespiration

-0.230

Nigericin50 uM Nigericinrespiration

0.074

TRC10-150 ug/mL Triclosanrespiration

-0.161

TRZ10-25 ug/mL Thioridazinerespiration

1.191

Valinomycin0.5-10 uM Valinomycinrespiration

0.742

ZnSO42 mM ZnSO4respiration

0.383

menadione6-10 ug/mL Menadionerespiration

-0.105

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.128

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.008

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.051

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.852

NRP_1Non-replicating persistence stage 1dosRassociated

0.117

Amp0.2mg/mL AmpicillincellWall

0.418

Cephalexin20-100 ug/mL CephalexincellWall

0.274

Cerulenin0.32-5 ug/mL CerulenincellWall

0.033

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.119

EMB10-20 ug/mL EthambutolcellWall

0.095

Eta12-40 ug/mL EthionamidecellWall

-0.009

INH0.2-0.4 ug/mL IsoniazidcellWall

0.025

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.464

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.194

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.034

BZA0.12 mg/mL BenzamidearomaticAmides

0.300

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.924

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.617

H2O24 mM hydrogen peroxideDNAdamaging

-0.043

Levo10 ug/mL LevofloxacinDNAdamaging

-0.679

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-1.007

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.677

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.553

UVUV-irradiationDNAdamaging

0.943

ARP41-4 ug/mL Antitubercular compound ARP4?

0.082

Antimycin12.5-50 ug/mL Antimycin A?

0.512

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-1.441

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.320

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.323

PA8240.2-2 ug/mL PA-824?

-0.140

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.708

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.654

Verapamil50 uM Verapamil?

0.501

mercaptoethanol2 mM 2-Mercaptoethanol?

0.150

methoxatin10-20 ug/mL Methoxatin?